News & Events
-
-
Press Announcements
-
-
-
May 2013
- May 17, 2013 - FDA seeks preliminary injunction against New York fish manufacturer
- May 15, 2013 - FDA approves Simponi to treat ulcerative colitis
- May 15, 2013 - La FDA aprueba nuevo medicamento para el cáncer de próstata avanzado
- May 15, 2013 - FDA approves new drug for advanced prostate cancer
- May 14, 2013 - FDA approves Nymalize--first nimodipine oral solution for use in certain brain hemorrhage patients
- May 14, 2013 - FDA approves first companion diagnostic to detect gene mutation associated with a type of lung cancer
- May 13, 2013 - FDA releases new tool to help prevent intentional food contamination
- May 10, 2013 - FDA warns consumers about potential health risk with Juices Incorporated juice products
- May 10, 2013 - FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease
- May 08, 2013 - FDA alerts health care providers of lack of sterility assurance of drug products from The Compounding Shop
- May 06, 2013 - FDA issues proposal to increase consumer awareness of tanning bed risks
- May 06, 2013 - FDA warns pregnant women to not use certain migraine prevention medicines
- May 06, 2013 - La FDA advierte a mujeres embarazadas que no usen ciertos medicamentos para prevenir migrañas
-
April 2013
- April 30, 2013 - FDA approves Plan B One-Step emergency contraceptive without a prescription for women 15 years of age and older
- April 30, 2013 - FDA approves Procysbi for rare genetic condition
- April 29, 2013 - FDA approves Kcentra for the urgent reversal of anticoagulation in adults with major bleeding
- April 24, 2013 - FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool
- April 24, 2013 - La FDA se asocia con otras organizaciones para la protección contra medicamentos antipalúdicos falsos a través del uso de un aparato portátil para la detección y desarrollado por la FDA
- April 21, 2013 - FDA announces voluntary nationwide recall by Balanced Solutions Compounding Pharmacy
- April 16, 2013 - FDA approves abuse-deterrent labeling for reformulated OxyContin
- April 15, 2013 - FDA issues alert about lack of sterility assurance of drug products from ApotheCure, Inc. and NuVision Pharmacy and of forthcoming recall
- April 15, 2013 - FDA: U.S. Marshals seize food at New York-based food facility
- April 10, 2013 - FDA budget requests $4.7 billion to ensure safety of food supply and to modernize medical product safety
- April 08, 2013 - La FDA aprueba Diclegis para las mujeres embarazadas que experimentan náuseas y vómitos
- April 08, 2013 - FDA approves Diclegis for pregnant women experiencing nausea and vomiting
-
March 2013
- March 29, 2013 - FDA approves Invokana to treat type 2 diabetes
- March 27, 2013 - FDA approves new multiple sclerosis treatment: Tecfidera
- March 22, 2013 - La FDA aprueba la primera antitoxina contra el botulismo para neutralizar todos los siete serotipos conocidos de la neurotoxina botulínica.
- March 22, 2013 - FDA approves first Botulism Antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes
- March 22, 2013 - FDA approves TOBI Podhaler to treat a type of bacterial lung infection in cystic fibrosis patients
- March 22, 2013 - FDA issues proposal to improve the quality of automated external defibrillators
- March 21, 2013 - FDA alerts health care providers and patients of the nationwide recall of all lots of sterile products distributed by Clinical Specialties Compounding Pharmacy
- March 20, 2013 - FDA approves Dotarem, a new magnetic resonance imaging agent
- March 18, 2013 - FDA alerts health care providers of recall of all sterile drug products by Med Prep Consulting in New Jersey
- March 18, 2013 - FDA warns consumers not to eat certain ProtiDiet High Protein Chocolate Dream Bars manufactured by Pro-Amino International, Inc., Quebec, Canada
- March 13, 2013 - FDA approves Lymphoseek to help locate lymph nodes in patients with certain cancers
- March 13, 2013 - Federal judge approves consent decree with New Jersey bakery
- March 08, 2013 - FDA issues draft guidance for manufacturers to accurately label medical products that are not made with natural rubber latex
-
February 2013
- February 26, 2013 - La FDA aprueba Osphena para mujeres postmenopáusicas que sufren dolor durante el acto sexual
- February 26, 2013 - FDA approves Osphena for postmenopausal women experiencing pain during sex
- February 25, 2013 - FDA approves Stivarga for advanced gastrointestinal stromal tumors
- February 24, 2013 - FDA alerts health care providers of recall of anemia drug Omontys
- February 22, 2013 - FDA enters into consent decree with Chicago sprout producer due to unsanitary conditions
- February 22, 2013 - La FDA aprueba un nuevo tratamiento para el cáncer de mama en etapa avanzada
- February 22, 2013 - FDA approves new treatment for late-stage breast cancer
- February 21, 2013 - Kasel Associates Industries recalling certain pet treats due to Salmonella contamination
- February 20, 2013 - FDA approves new silicone breast implant
- February 20, 2013 - FDA seeks input on minimizing disruptions to medical device supply chain during extreme weather events
- February 14, 2013 - U.S. Marshals seize drug products distributed by a Florida company
- February 14, 2013 - La FDA aprueba el primer implante de retina para adultos con enfermedad ocular genética rara
-
-
-
-
